Publicaciones en colaboración con investigadores/as de Albert Einstein College of Medicine (49)

2024

  1. Association of Tumor Mutational Burden and Microsatellite Instability With Response and Outcomes in Patients With Urothelial Carcinoma Treated With Immune Checkpoint Inhibitor

    Clinical Genitourinary Cancer, Vol. 22, Núm. 6

  2. Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized, double-blind, phase 3 trial

    Lung Cancer, Vol. 189

  3. Pembrolizumab Plus Chemotherapy for Metastatic NSCLC With Programmed Cell Death Ligand 1 Tumor Proportion Score Less Than 1%: Pooled Analysis of Outcomes After Five Years of Follow-Up

    Journal of Thoracic Oncology, Vol. 19, Núm. 8, pp. 1228-1241

2023

  1. Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC

    JTO Clinical and Research Reports, Vol. 4, Núm. 1

  2. Pembrolizumab Plus Chemotherapy in Squamous Non-Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study

    Journal of Clinical Oncology, Vol. 41, Núm. 11, pp. 1999-2006

  3. Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): “Real World” Experience

    Clinical Genitourinary Cancer, Vol. 21, Núm. 5, pp. 584-593

2022

  1. A normative chart for cognitive development in a genetically selected population

    Neuropsychopharmacology, Vol. 47, Núm. 7, pp. 1379-1386

  2. Global Circumferential and Radial Strain Among Patients With Immune Checkpoint Inhibitor Myocarditis

    JACC: Cardiovascular Imaging, Vol. 15, Núm. 11, pp. 1883-1896

  3. Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis

    Journal of the International AIDS Society, Vol. 25, Núm. 3

2021

  1. Autophagy in major human diseases

    EMBO Journal, Vol. 40, Núm. 19

  2. Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion

    Molecular Psychiatry, Vol. 26, Núm. 8, pp. 4496-4510

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  4. Manifesto for an ECNP Neuromodulation Thematic Working Group (TWG): Non-invasive brain stimulation as a new Super-subspecialty

    European Neuropsychopharmacology, Vol. 52, pp. 72-83

  5. Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor–Associated Myocarditis

    Journal of the American College of Cardiology, Vol. 77, Núm. 12, pp. 1503-1516

  6. Recurrence of iga nephropathy after kidney transplantation in adults

    Clinical Journal of the American Society of Nephrology, Vol. 16, Núm. 8, pp. 1247-1255

  7. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

    npj Breast Cancer, Vol. 7, Núm. 1

  8. Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders

    JAMA Psychiatry, Vol. 78, Núm. 1, pp. 47-63

2020

  1. Coronary artery aneurysms, insights from the international coronary artery aneurysm registry (CAAR)

    International Journal of Cardiology, Vol. 299, pp. 49-55

  2. Using common genetic variation to examine phenotypic expression and risk prediction in 22q11.2 deletion syndrome

    Nature Medicine, Vol. 26, Núm. 12, pp. 1912-1918

2019

  1. Neoadjuvant trastuzumab emtansine and pertuzumab in human epidermal growth factor receptor 2–positive breast cancer: Three-year outcomes from the phase III KristinE study

    Journal of Clinical Oncology